https://mdtechcouncil.com/maryland-tech-council-announces-2024-icon-award-finalists/
GlycoMantra received a CDMRP grant from the DOD.
June 12, 2018
GlycoMantra received a CDMRP grant from the DOD.
GlycoMantra was awarded a CDMRP grant to develop personalized cellular immunotherapy for kidney cancer.